Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy (vol 117, pg 858, 2001)

被引：0
作者：
Pellet, C
Chevret, S
Blum, L
Gauville, C
Hurault, M
Blanchard, G
Agbalika, F
Lascoux, C
Ponscarme, D
Morel, P
Calvo, F
Lebbe, C
机构：
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2002年 / 118卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：741 / 741
页数：1
相关论文
共 50 条
  • [21] Complete regression of AIDS-related Kaposi's sarcoma in a child treated with highly active antiretroviral therapy
    Niehues, T
    Horneff, G
    Megahed, M
    Schroten, H
    Wahn, V
    AIDS, 1999, 13 (09) : 1148 - 1149
  • [22] Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-iInfected women
    Vaamonde, CM
    Hoover, DR
    Anastos, K
    Tan, T
    Shi, Q
    Gao, W
    Kovacs, A
    Cohen, M
    DeHovitz, J
    Glesby, MJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (03) : 222 - 231
  • [23] Fatal Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral therapy
    Kawsar, M
    INTERNATIONAL JOURNAL OF STD & AIDS, 2005, 16 (08) : 582 - 583
  • [24] Therapeutic Outcomes in AIDS-Associated Kaposi's Sarcoma Patients on Antiretroviral Therapy Treated with Chemotherapy at Two Tertiary Hospitals in Lusaka, Zambia
    Mtonga, Watson
    Mujajati, Aaron
    Munkombwe, Derick
    Kalungia, Aubrey
    Muungo, Lungwani Tyson
    West, John
    Wood, Charles
    Ngalamika, Owen
    CURRENT HIV RESEARCH, 2018, 16 (03) : 231 - 236
  • [25] An evaluation of the early effects of a combination antiretroviral therapy programme on the management of AIDS-associated Kaposi's sarcoma in KwaZulu-Natal, South Africa
    Mosam, A.
    Uldrick, T. S.
    Shaik, F.
    Carrara, H.
    Aboobaker, J.
    Coovadia, H.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2011, 22 (11) : 671 - 673
  • [26] Type 1 and type 2 cytokine profile in AIDS-Kaposi's sarcoma patients after highly active antiretroviral therapy
    Sirianni, MC
    Vincenzi, L
    Topino, S
    Mezzaroma, I
    Pinter, E
    Barbone, B
    Monini, P
    Ensoli, B
    FOURTH EUROPEAN CONFERENCE ON EXPERIMENTAL AIDS RESEARCH, 1999, : 167 - 171
  • [27] Treatment Outcomes of AIDS-Associated Kaposi's Sarcoma under a Routine Antiretroviral Therapy Program in Lilongwe, Malawi: Bleomycin/Vincristine Compared to Vincristine Monotherapy
    Mwafongo, Albert A.
    Rosenberg, Nora E.
    Ng'ambi, Wingston
    Werner, Alexandra B.
    Garneau, William M.
    Gumulira, Joe
    Phiri, Sam
    Hosseinipour, Mina C.
    PLOS ONE, 2014, 9 (03):
  • [28] Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy
    Mezzaroma, I
    Carlesimo, M
    Pinter, E
    Muratori, DS
    Di Sora, F
    Chiarotti, F
    Cunsolo, MG
    Sacco, G
    Aiuti, F
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (06) : 1423 - 1430
  • [29] AIDS-related Kaposi’s sarcoma: outcomes after initiation of highly active antiretroviral therapy under routine conditions in Zimbabwe
    Bradley Nelson
    Margaret Borok
    Tariro Makadzange
    Tafadzwa Mhlanga
    Thomas Campbell
    Infectious Agents and Cancer, 5 (Suppl 1)
  • [30] Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy
    Grabar, S
    Le Moing, V
    Goujard, C
    Leport, C
    Kazatchkine, MD
    Costagliola, D
    Weiss, L
    ANNALS OF INTERNAL MEDICINE, 2000, 133 (06) : 401 - 410
12345